ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic Dermatitis

NCT06248814 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy

NCT03720470 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis

NCT07205081 ·Status: RECRUITING ·Phase: PHASE1

Efficacy and Safety of Orally Administered DS107 in Adult Patients With Moderate to Severe Atopic Dermatitis

NCT03817190 ·Status: TERMINATED ·Phase: PHASE2

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis

NCT00717769 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis

NCT04212169 ·Status: COMPLETED ·Phase: PHASE2

A Trial of Antroquinonol in Patients With Atopic Dermatitis

NCT03622463 ·Status: COMPLETED ·Phase: PHASE2

Effect of OC000459 on Moderate to Severe Atopic Dermatitis

NCT02002208 ·Status: COMPLETED ·Phase: PHASE2

Oral DS107 in Moderate to Severe Atopic Dermatitis

NCT02211417 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis

NCT02087943 ·Status: COMPLETED ·Phase: PHASE2

Phase 2a Study of the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic Dermatitis

NCT04992546 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

NCT03422822 ·Status: COMPLETED ·Phase: PHASE3

Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis

NCT02780167 ·Status: COMPLETED ·Phase: PHASE2

Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis

NCT04975438 ·Status: COMPLETED ·Phase: PHASE1

A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

NCT07105488 ·Status: RECRUITING ·Phase: PHASE2

Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis

NCT07220577 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)

NCT03345914 ·Status: COMPLETED ·Phase: PHASE3

A Study Evaluating TRIV-509 in Atopic Dermatitis

NCT07167758 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Evaluate the Safety and Tolerability of MOR106 Administered Concomitantly With Topical Corticosteroids, in Adult Participants With Moderate to Severe Atopic Dermatitis

NCT03864627 ·Status: TERMINATED ·Phase: PHASE2

Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic Dermatitis

NCT04413942 ·Status: UNKNOWN ·Phase: PHASE2

This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD).

NCT05935085 ·Status: TERMINATED ·Phase: PHASE2

Sublingual Immunotherapy in Patients With Atopic Dermatitis

NCT01471119 ·Status: COMPLETED ·Phase: PHASE2

A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo

NCT01299610 ·Status: COMPLETED ·Phase: PHASE2

Study of TER-101 Topical Ointment in Subjects With Atopic Dermatitis

NCT04753034 ·Status: COMPLETED ·Phase: PHASE2

A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisable

NCT03428100 ·Status: COMPLETED ·Phase: PHASE3